News

Presentation of the iPiE project at the SETAC Europe meeting

The project Intelligence-led assessment of pharmaceuticals in the environment (iPiE) will be presented at the SETAC Europe Annual Meeting in Helsinki, at a symposium organised by the SETAC Europe Pharmaceutical Interest Group. The symposium will take place on Sunday, 26 May 2019 (13:00 – 17:30). Its aim is to present the iPiE project in detail […]

New publication: Impact of an immunosuppressive human pharmaceutical on the interaction of a bacterial parasite and its invertebrate host

The interaction of pollutants and pathogens may result in altered (often enhanced) effects of the chemical, the biotic stressor or both. While standardised detection methods for immunotoxic effects of chemicals exist with regard to human health, such test systems are lacking for invertebrate species and no guidance is available on how immunotoxic effects of a […]

Interview with Anja Coors in the current iPiE Newsletter

ECT is involved in the project ‘Intelligence-led assessment of pharmaceuticals in the environment’ (iPiE).  The iPiE project contributes to developing frameworks for intelligence-based environmental testing of pharmaceuticals and for prioritising legacy pharmaceuticals for targeted environmental risk assessment and environmental (bio-) monitoring. The current iPiE newsletter (Newsletter No 6) features an interview with Anja Coors, who […]